# Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence

> **NCT06120127** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 80 (estimated)

## Conditions studied

- Radiotherapy
- Immunotherapy
- Liver Metastases
- Colorectal Cancer

## Interventions

- **RADIATION:** SBRT
- **DRUG:** Chemotherapy
- **DRUG:** PD-1 antibody

## Key facts

- **NCT ID:** NCT06120127
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-25
- **Primary completion:** 2025-09-25
- **Final completion:** 2025-09-25
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06120127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06120127, "Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06120127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*